CEO Interviews | The Wall Street Analyzer - Part 5

Latest News

[ February 12, 2025 ] VSee Health Announces Contract with Top Kidney Care Provider to Add VSee Workflow to Oracle Cerner EHR News Feed
[ February 7, 2025 ] Greenlite Venture Signs Letter of Intent to Acquire TicketBash.com News Feed
[ February 5, 2025 ] NoLimitCoin Expands to Polygon (POL) and Ethereum (ETH) Networks adding to the (BSC) network, Boosting Greenlite Ecosystem. Consumer
[ February 4, 2025 ] Soligenix to Present at BIO CEO & Investor Conference News Feed
[ January 30, 2025 ] Midnight Sun Intersects High-Grade Oxide Copper at Kazhiba Target Market News
[ January 21, 2025 ] Coinbase CEO Brian Armstrong: It’s really the dawn of a new day for crypto Market News
[ January 14, 2025 ] HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma News Feed

Ra Medical Systems (NYSE American: RMED)

February 25, 2023 The Wall Street Analyzer Comments Off

Interview with David Jenkins, Executive Chairman […]

Acutus Medical (NASDAQ: AFIB)

February 24, 2023 The Wall Street Analyzer Comments Off

Interview update with David Roman, CEO and President […]

CEO Interviews

Pro-Dex, Inc (NASDAQ: PDEX)

February 22, 2023 The Wall Street Analyzer Comments Off

Interview update with Rick Van Kirk, CEO
[…]

No Picture

Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF)

February 22, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP)

February 16, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

Castellum, Inc (NYSE American: CTM)

February 15, 2023 The Wall Street Analyzer Comments Off

Interview with Mark Fuller, CEO and President
[…]

No Picture

Candel Therapeutics (NASDAQ: CADL)

February 7, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

CEO Interviews

Power Nickel Inc. (TSX-V: PNPN)(OTCQB:CMETF)

February 6, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

BuildDirect.com Technologies (TSXV: BILD)

February 6, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF)

February 1, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com